Search

everythinglearnresearchcommunity

for

Search:↓

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

The reviews highlighted practical advice and insights from various psychology and therapy books.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

Children with trichotillomania often pull hair from their scalp, and parents may not notice; stress can trigger it, and asking detailed questions helps in diagnosis and treatment.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Trichotillomania is more common than previously thought, with increasing diagnosed cases.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

A teenager lost hair due to fluoxetine and sertraline, but it grew back after stopping these drugs and switching to a different one.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Aesthetic medicine needs clear ethical guidelines to ensure patient well-being and safety.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.